Nectar Lifesciences Limited
NSE:NECLIFE.NS
39.69 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 16,856.313 | 15,236.695 | 16,688.32 | 15,432.97 | 23,663.79 | 27,828.65 | 18,762.57 | 16,437 | 16,756.87 | 16,428.89 | 16,377.69 | 16,248.15 | 13,032.88 | 10,554.48 | 8,858.22 | 7,799.77 | 7,744.99 | 4,688.682 | 2,905.228 |
| Cost of Revenue
| 13,476.309 | 11,592.85 | 13,695.05 | 12,857.27 | 19,975.6 | 23,708.15 | 15,110.46 | 12,818.73 | 12,772.9 | 12,566.86 | 12,529.12 | 12,358.38 | 9,892.04 | 7,540.78 | 93.95 | -73.42 | 95.27 | -137.245 | -67.698 |
| Gross Profit
| 3,380.004 | 3,643.845 | 2,993.27 | 2,575.7 | 3,688.19 | 4,120.5 | 3,652.11 | 3,618.27 | 3,983.97 | 3,862.03 | 3,848.57 | 3,889.77 | 3,140.84 | 3,013.7 | 8,764.27 | 7,873.19 | 7,649.72 | 4,825.927 | 2,972.926 |
| Gross Profit Ratio
| 0.201 | 0.239 | 0.179 | 0.167 | 0.156 | 0.148 | 0.195 | 0.22 | 0.238 | 0.235 | 0.235 | 0.239 | 0.241 | 0.286 | 0.989 | 1.009 | 0.988 | 1.029 | 1.023 |
| Reseach & Development Expenses
| 143.56 | 26.54 | 30.7 | 24.35 | 24.46 | 0 | 60.09 | 86.22 | 360.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 171.9 | 142.83 | 150.16 | 174.11 | 175.5 | 196.34 | 196.03 | 166.44 | 167.57 | 181.03 | 190.78 | 159.14 | 211.21 | 225.68 | 114.11 | 170.15 | 106.56 | 57.181 | 34.072 |
| Selling & Marketing Expenses
| 389.91 | 428.67 | 480.27 | 507.87 | 463.65 | 456.59 | 287.17 | 389.99 | 343.22 | 352.53 | 247.12 | 298.36 | 188.6 | 210.75 | 224.66 | 217.57 | 161.95 | 102.154 | 72.824 |
| SG&A
| 2,456.198 | 571.5 | 630.43 | 681.98 | 639.15 | 652.93 | 483.2 | 556.43 | 510.79 | 533.56 | 437.9 | 457.5 | 399.81 | 436.43 | 338.77 | 387.72 | 268.51 | 159.335 | 106.896 |
| Other Expenses
| 130.3 | 422.393 | 112.93 | 27.221 | 9.8 | 1,455.33 | 1,445.71 | 1,437.33 | 1,506.17 | 1,424.55 | 1,364.98 | 1,290.46 | 985.7 | 641.5 | 6,778.25 | 6,397.18 | 6,072.89 | 3,916.932 | 2,168.123 |
| Operating Expenses
| 2,456.198 | 3,695.566 | 1,977.28 | 1,954.64 | 2,094.88 | 2,108.26 | 1,928.91 | 1,993.76 | 2,016.96 | 1,958.11 | 1,802.88 | 1,747.96 | 1,385.51 | 1,077.93 | 7,117.02 | 6,784.9 | 6,341.4 | 4,076.267 | 2,275.018 |
| Operating Income
| 923.806 | -51.73 | 1,015.97 | 499.91 | 1,593.32 | 2,012.24 | 1,723.2 | 1,624.51 | 1,967.01 | 1,903.92 | 2,045.69 | 2,141.81 | 1,755.33 | 1,935.77 | 1,647.25 | 1,088.29 | 1,308.32 | 749.66 | 697.908 |
| Operating Income Ratio
| 0.055 | -0.003 | 0.061 | 0.032 | 0.067 | 0.072 | 0.092 | 0.099 | 0.117 | 0.116 | 0.125 | 0.132 | 0.135 | 0.183 | 0.186 | 0.14 | 0.169 | 0.16 | 0.24 |
| Total Other Income Expenses Net
| -741.117 | -372.47 | -675.16 | -1,347.59 | -1,218.61 | -1,424.04 | -1,096.37 | -950.34 | -1,242.11 | -1,056.38 | -1,263.41 | -994.3 | -901.01 | -731.39 | -494.26 | -446.66 | -480.8 | -218.551 | -241.318 |
| Income Before Tax
| 182.689 | -424.2 | 340.8 | -847.67 | 374.71 | 588.2 | 626.83 | 674.17 | 724.9 | 847.54 | 782.28 | 1,147.51 | 854.32 | 1,204.38 | 1,152.99 | 641.63 | 827.52 | 531.109 | 456.589 |
| Income Before Tax Ratio
| 0.011 | -0.028 | 0.02 | -0.055 | 0.016 | 0.021 | 0.033 | 0.041 | 0.043 | 0.052 | 0.048 | 0.071 | 0.066 | 0.114 | 0.13 | 0.082 | 0.107 | 0.113 | 0.157 |
| Income Tax Expense
| 132.743 | -182.371 | 90.34 | -115.04 | 56.82 | 112.2 | 104.11 | 120.79 | 132.96 | 184.9 | 161.43 | 290.09 | 122.16 | 173.47 | 230.1 | 111.89 | 80.13 | 63.831 | 76.703 |
| Net Income
| 49.95 | -241.829 | 250.47 | -732.64 | 317.89 | 476 | 522.72 | 553.38 | 591.94 | 662.64 | 620.86 | 857.42 | 732.16 | 1,030.91 | 922.89 | 529.74 | 747.39 | 467.278 | 379.886 |
| Net Income Ratio
| 0.003 | -0.016 | 0.015 | -0.047 | 0.013 | 0.017 | 0.028 | 0.034 | 0.035 | 0.04 | 0.038 | 0.053 | 0.056 | 0.098 | 0.104 | 0.068 | 0.096 | 0.1 | 0.131 |
| EPS
| 0.22 | -1.08 | 1.12 | -3.27 | 1.42 | 2.12 | 2.33 | 2.47 | 2.42 | 2.95 | 2.77 | 3.82 | 3.26 | 4.65 | 5.83 | 3.47 | 4.97 | 3.04 | 2.76 |
| EPS Diluted
| 0.22 | -1.08 | 1.12 | -3.27 | 1.42 | 2.12 | 2.33 | 2.47 | 2.42 | 2.95 | 2.77 | 3.82 | 3.26 | 4.65 | 4.29 | 2.53 | 3.57 | 2.22 | 2.76 |
| EBITDA
| 1,530.99 | 961.861 | 1,515.82 | 986.78 | 1,897.59 | 2,101.27 | 2,150.16 | 2,080.39 | 2,441.28 | 2,453.31 | 2,505.21 | 2,956.23 | 2,491.56 | 2,406.3 | 2,034.79 | 1,391.36 | 1,503.11 | 865.434 | 781.513 |
| EBITDA Ratio
| 0.091 | 0.063 | 0.091 | 0.064 | 0.08 | 0.076 | 0.115 | 0.127 | 0.146 | 0.149 | 0.153 | 0.182 | 0.191 | 0.228 | 0.23 | 0.178 | 0.194 | 0.185 | 0.269 |